House Committee rejects cancer drugs petition

Sneh slams opposition leaders for using the cancer patients to gain popularity.

May 22, 2006 23:45
1 minute read.
colon cancer strike ch1 298

coloncancerstrikech1298. (photo credit: Channel 1)


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


The Knesset House Committee rejected on Tuesday the petition of Likud MK Danny Naveh to include the cancer-fighting drugs Erbitx and Avastin in the 2006 health basket, by 14 votes to 11. MK Ephraim Sneh (Kadima) accused Naveh and other opposition leaders of using the cancer patients to gain popularity. "I hope that your conscience will soon be clear", Sneh exclaimed. Tensions flared in the meeting prior to the vote with insults flying between the two MKs. Sneh called Naveh "immoral" and queried why Naveh didn't included the medicines when when he was health minister two-and-a-half years ago. The two MKs were unable to maintain control and chairperson Ruhama Avraham was forced to call a 30 minute break. President Moshe Katsav had urged the government and the Knesset on Monday to speed up their decisions to expand the health basket to include those life-prolonging medications for cancer patients that are currently not in the basket. Rafi Eitan suggested that private organizations could shoulder the cost of the drugs until the state found a way to allocate funds. Eitan's proposal was blasted by Labor and Likud MKs, who called it a Band-Aid on a much larger problem. Sharoni added that moving the discussion into the committee would only stall the process further. Although Prime Minister Ehud Olmert had asked the health basket committee to meet again to discuss the possibility of including the two drugs in the basket, committee chairman Mordechai Shani said there was no point in meeting again unless the Treasury allocated more money to add the drugs. The committee would not change its priority list to substitute Erbitux and Avastin for lifesaving drugs already added to the basket, Shani said. Meanwhile, Sharoni's committee decided to reject the section of the Arrangements Bill prepared by the Treasury that would allow licensed pharmacists to issue prescriptions for drugs without a doctor's involvement. Sharoni said that such a change would have major implications on medical care and could not be included in the bill without serious discussion. The Health Ministry, said the Knesset committee chairman, could present the idea for discussion separately. Judy Siegel contributed to this report.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

Jisr az-Zarq
April 3, 2014
Residents of Jisr az-Zarqa beckon Israel Trail hikers to enjoy their town